Bjorn Brandsaeter, Erik Schrumpf, Oystein Bentdal, Kurt Brabrand, Hans Jorgen Smith, Andreas Abildgaard, Ole Petter Clausen, Kristian Bjoro – 23 September 2005 – Primary sclerosing cholangitis (PSC) is a well‐established indication for orthotopic liver transplantation (OLT), but post‐OLT bile duct strictures complicate the outcome for these patients. These strictures might represent recurrent PSC (rPSC).

Hubert Hetz, Michael Bauer, Daniel Lahner, Peter Faybik, Johannes Winning, Hendrik Jan Ankersmit, Andreas Bacher, Claus Georg Krenn – 23 September 2005 – Renal failure is an established risk factor for impaired patient outcome after orthotopic liver transplantation (OLT). As the endothelin pathway is known to be involved in the development of acute renal failure (ARF), we designed a study to clarify its role in ARF following OLT. Twenty consecutive patients with intact kidney function scheduled for their first OLT were prospectively studied.

Peter Stärkel, Michel Stoffel, Jan Lerut, Yves Horsmans – 23 September 2005 – Strategies using lamivudine and hepatitis B immunoglobulins (HBIg) for prevention of hepatitis B virus (HBV) reinfection after liver transplantation (LT) are expensive since life‐long treatment is needed.

23 September 2005

Peter L. Abt, Ibrahim Abdullah, Kathleen Korenda, Adam Frank, Heather Peterman, G. Robert Stephenson, James F. Markmann, Abraham Shaked, Kim M. Olthoff – 23 September 2005 – Appendicitis among liver transplant recipients has not been described in the current literature. We report 8 recipients who experienced appendicitis three weeks to 181 months after liver transplantation (LT). Initial presenting findings differed from the nonimmunosuppressed population in that a majority of the patients did not have leukocytosis (>10,000 cells/mm3).

Neal R. Barshes, Timothy C. Lee, Rajesh Balkrishnan, Saul J. Karpen, Beth A. Carter, John A. Goss – 23 September 2005 – Biliary atresia is the most common indication for orthotopic liver transplantation (OLT) in the pediatric population. The outcomes of liver transplantation for biliary atresia, however, have not been formally examined on a national scale. The objective of this study was to identify pretransplant variables that predict patient survival after primary liver transplantation for biliary atresia.

Shimon Kusne, Jerry Smilack – 23 September 2005

John Fung, Jorge Rakela – 23 September 2005

Pietro Majno, Gilles Mentha, Vincenzo Mazzaferro – 23 September 2005

Shin Hwang, Sung‐Gyu Lee, Jae‐Won Joh, Kyung‐Suk Suh, Dong‐Goo Kim – 23 September 2005 – Current selection criteria of liver transplantation (LT) for patients with hepatocellular carcinoma (HCC) were derived from the outcomes of cadaveric donor LT (CDLT). We tried to assess the applicability of such criteria to living donor LT (LDLT) through a comparative study between CDLT and LDLT. We analyzed the outcomes of 312 HCC patients who underwent LT at 4 Korean institutions during 1992 to 2002.